Israel

Teva Pharmaceutical has started commercial shipment of 25mg, 100mg, 150mg and 200mg doses of its generic version of Glaxosmithkline (GSK)'s Lamictal (lamotrigine) in the US.

According to Globes [online], a survey by the Manufacturers Association of Israel reported that pharmaceutical exports grew by 44% in Q208 from Q1. The survey also showed that the... 2008-07-24

Not to be outdone by its research-focused rivals, Israel's Teva Pharmaceutical Industries has once again demonstrated its desire to expand by acquisition, launching a US$7.46bn bid... 2008-07-21

Following the rejection of its merger agreement with Israel-based drug manufacturer Taro Pharma , India's Sun Pharma has launched a hostile takeover bid.

The US FDA has accepted for review Momenta Pharmaceuticals' generic version of Teva Pharmaceutical's Copaxone (glatiramer).

US-based Mylan has signed an agreement with India's NATCO Pharma to market a generic version of Israeli drugmaker Teva's multiple sclerosis drug Copaxone (glatiramer) in the US, Europe,... 2008-06-12

Surprising many industry observers, BMI included, on May 28 Israel's Taro Pharmaceutical Industries terminated its proposed merger with India's Sun Pharmaceutical Industries, bringing... 2008-05-29

In terms of volume, the Office of the US Trade Representative (USTR)'s 2008 Special 301 Report suggests that BMI's belief that this year will see the US push to improve intellectual... 2008-05-01

A poll by Israeli research institute Geocartography Knowledge Group (GCKG) into citizens' views on the country's healthcare system has found substantial opposition to the gradual... 2008-03-14

In a move that BMI interprets as a signal that India's Sun Pharmaceutical Industries is growing impatient with opposition to its proposed acquisition of Israel's Taro Pharmaceutical... 2008-02-25